Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

Novel adjuvants present a concern for adverse effects, generating a need for alternatives. Rotavirus inner capsid VP6 protein could be considered a potential candidate, due to its ability to self-assemble into highly immunogenic nanospheres and nanotubes. These nanostructures exhibit immunostimulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinimäki, Suvi, Tamminen, Kirsi, Hytönen, Vesa P., Malm, Maria, Blazevic, Vesna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565724/
https://www.ncbi.nlm.nih.gov/pubmed/32645976
http://dx.doi.org/10.3390/vaccines8030365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565724/
https://www.ncbi.nlm.nih.gov/pubmed/32645976
http://dx.doi.org/10.3390/vaccines8030365

Ejemplares similares